Latest Macula Stories

2010-10-20 13:45:04

Anatomical and functional impairment of the retina and optic nerve in patients with anorexia nervosa without vision loss The eating disorder anorexia nervosa causes potentially serious eye damage, suggests a small study published online in the British Journal of Ophthalmology. In developed countries, anorexia nervosa affects up to 3% of affluent women. Although the condition also increasingly affects men, around 10 women will be affected for every one man. Anorexia nervosa is the third most...

2010-09-05 23:59:00

LEUVEN, Belgium, September 6, 2010 /PRNewswire-FirstCall/ -- - Data Presented at EURETINA Highlight the Attractive Characteristics of this Novel Potential Treatment Option for Retinal Disorders ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were...

2010-09-01 00:29:00

LEUVEN, Belgium, September 1, 2010 /PRNewswire-FirstCall/ -- - Data Presented at ASRS Confirm Previous Phase III Findings and Microplasmin's Potential to Transform the Treatment of Retinal Disorders ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of...

2010-07-28 10:33:25

Seahorses are helping scientists gain new understanding about how detailed vision develops "“ in research which may open a way to restore sight in people with age-related blinding diseases. Researchers at the Vision Centre have found that the seahorses' eyes share similarities with the human eye, leading to the possibility of imitating the development of the seahorse's fovea to regenerate this vital region of the eye in people with impaired vision. "The fovea is the tiny pit at the back...

2010-07-06 08:00:00

SARATOGA, Calif., July 6 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the U.S. Food and Drug Administration (FDA) has approved the company's Implantable Miniature Telescope (by Dr. Isaac Lipshitz) to improve vision in patients with end-stage age-related macular degeneration (AMD). VisionCare's first-of-kind telescope implant is integral to a new patient care program, CentraSight, for treating patients with...

2010-05-04 12:00:00

SUNNYVALE, Calif., May 4 /PRNewswire/ -- Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it will present an abstract demonstrating the utility of its Verisome(TM) Liquid Drug Delivery System in cystoid macular edema, at the Association for Research in Vision and Ophthalmology (ARVO) 2010 annual meeting, taking place May 2-6, 2010, in Fort Lauderdale,...

2010-05-04 10:07:00

ST. LOUIS, May 4 /PRNewswire/ -- ZeaVision, LLC introduced Eye-Q(TM), an intelligent AMD Risk Management program for EyeCare Professionals and patients to manage a key risk factor for Age-related Macular Degeneration (AMD). AMD is a debilitating disease that affects the macula in the center of the eye, which is responsible for central vision. Affecting approximately 15 million people, AMD is irreversible and the leading cause of blindness in people over age 55. The Eye-Q(TM) program...

2010-04-27 14:22:59

Ranibizumab injections plus laser therapy results in dramatic visual improvement Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina. Laser treatment alone has been the standard care for the past 25 years. But nearly 50 percent of patients who received this new treatment experienced substantial visual improvement after one year, compared...

2010-03-24 15:30:00

NEW YORK -- Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema. Researchers at the Wilmer Eye Institute of Johns Hopkins University School of Medicine in Maryland completed a multicenter human clinical trial treating diabetic macular edema with mecamylamine, a topical drug developed by the South San Francisco biotech company...

2010-03-04 16:30:00

Why our peripheral vision may not be as random as we think As you read this, you may notice that the word directly in front of you is clear, but all the surrounding words are hard to make out. For most people, this effect "“ known as 'crowding' "“ is not a problem. However, for the millions of people worldwide who have lost their central vision through eye disease such as macular degeneration, it can make everyday tasks such as reading or recognising friends a challenge. Despite...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'